JILLIAN STANCEVIC: Open Payments
NPI 1033615786 · FRANKLIN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$759 in 11 payments from 9 companies in 2025. Trend: 2023 $1,002 · 2024 $158 · 2025 $759
Food & beverage: $759
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 2 | $151 |
| BridgeBio Pharma, Inc. | 1 | $149 |
| E.R. Squibb & Sons, L.L.C. | 1 | $127 |
| Eisai Inc. | 1 | $122 |
| Boston Scientific Corporation | 1 | $112 |
| Biogen, Inc. | 2 | $33 |
| ARGENX US, INC. | 1 | $26 |
| Lundbeck LLC | 1 | $24 |
| Invivyd Inc | 1 | $15 |
Products named: Attruby, CAMZYOS, Leqembi, AMVUTTRA, WATCHMAN Access System, TYSABRI, ONPATTRO, VYVGART HYTRULO.
Industry payments across WI — which companies pay providers there.
